Cryptococcal epidemiology is changing in the modern anti-retroviral era, and immune status informs outcomes. We describe the differences in clinical presentation and mortality of cryptococcosis by immune status in the ART era.
Presentation and Mortality of Cryptococcal Infection Varies by Predisposing Illness, A Retrospective Cohort Study
Cryptococcal epidemiology is changing in the modern anti-retroviral era, and immune status informs outcomes. We describe the differences in clinical presentation and mortality of cryptococcosis by immune status in the ART era.